Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like World's Smartest Billionaire Upped Position in This Bay Area Biotech March 14, 2017 FDA Demands Karyopharm Stop Enrollment of All Selinexor Trials March 12, 2017 FDA Rejects Agile's Contraceptive Patch Twirla For a Second Time December 21, 2017
